Status:
COMPLETED
Effectiveness of Rice Germ Supplementation on Body Composition, Metabolic Parameters, Satiating Capacity and Amino Acid Profiles in Obese Postmenopausal Women
Lead Sponsor:
Azienda di Servizi alla Persona di Pavia
Conditions:
Obesity
Eligibility:
FEMALE
50-65 years
Phase:
NA
Brief Summary
Rice germ (RG) may be a safe and effective dietary supplement for obesity in menopause, considering its high protein content and considerable amounts of essential amino acids, good fatty acids, and fi...
Eligibility Criteria
Inclusion
- obesity (BMI 30-40 kg/m2)
- age 50-65
- menopause
- sedentary women and non-smoking,
- women who did not drink more than six glasses (one glass: 125 mL) of wine a week and did not drink hard liquor (alcohol content at least 20% alcohol by volume)
- women who agreed not to take part in any other weight loss program
Exclusion
- evidence of heart, kidney or liver disease
- women who met the Diagnostic and Statistical Manual-IV (DSM-V) criteria for a current diagnosis of major depressive disorder
- taking any medications for weight loss
- control of cholesterol and triglycerides for anti-inflammatory purposes
- pregnancy
- lactating
- Type 1 diabetes mellitus, irritable bowel disease, celiac disease, chronic pancreatitis
- antibiotic use in the last three months
- probiotic/prebiotic treatment in the last four weeks.
Key Trial Info
Start Date :
January 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 27 2019
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04695418
Start Date
January 28 2018
End Date
December 27 2019
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda di Servizi alla Persona
Pavia, Italy, 27100